NCT05541185

Brief Summary

Purpose: The study was conducted to determine the effect of 1 ml of nigella sativa oil applied for 2 minutes three times a day for 21 days on pain severity and physical functions in patients with knee osteoarthritis (OA). Design and methods: This randomized controlled study was conducted with patients diagnosed with knee OA and admitted to the physical therapy outpatient clinic of a public hospital in Turkey between February 15, 2021 and March 31, 2021. A total of 75 patients were included in the study, and 25 of them were assigned to the nigella sativa oil group, 25 to the naproxen and lidocaine gel group, and 25 to the massage group. Research data were collected using the "Patient Information Form", "Western Ontario and McMaster Universities Osteoarthritis Index (Western Ontario and McMaster Universities Osteoarthritis Index = WOMAC)" and knee joint range measurements were made. For 21 days, both knees were massaged for 2 minutes 3 times a day, 1 ml of nigella sativa oil was applied to the patients in the nigella sativa oil group, 1 ml of naproxen and lidocaine gel was applied to the patients in the naproxen and lidocaine gel group, and 1 ml of liquid vaseline was applied to the patients in the massage group.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P50-P75 for not_applicable knee-osteoarthritis

Timeline
Completed

Started Feb 2021

Shorter than P25 for not_applicable knee-osteoarthritis

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 15, 2021

Completed
7 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 22, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2021

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

August 28, 2022

Completed
18 days until next milestone

First Posted

Study publicly available on registry

September 15, 2022

Completed
Last Updated

September 14, 2023

Status Verified

September 1, 2023

Enrollment Period

7 days

First QC Date

August 28, 2022

Last Update Submit

September 13, 2023

Conditions

Keywords

NursingOsteoarthritisNigella sativaPainMassage

Outcome Measures

Primary Outcomes (1)

  • 1st Measurement

    In the first measurement, "Western Ontario and McMaster Universities Osteoarthritis Index" were applied to the patients included in the Nigella sativa oil, naproxen and lidocaine gel and massage groups. The scores that can be obtained from the scale are 0-20 for pain, 0-8 for stiffness, and 0-68 for difficulty in performing daily physical activities. Higher scores indicate more symptoms and increased physical limitation.

    first day

Secondary Outcomes (1)

  • 2nd Measurement/ seventh day

    seventh day

Other Outcomes (2)

  • 3rd Measurement

    the fourteenth day

  • 4th Measurement

    twenty-first day

Study Arms (3)

Nigella sativa oil group

EXPERIMENTAL

1 ml of nigella sativa oil was applied to both knee areas of the nigella sativa oil group by massaging for 2 minutes three times a day for 21 days.

Biological: Nigella sativa oil

Naproxen and lidocaine gel group

EXPERIMENTAL

1 ml of naproxen and lidocaine gel was applied to both knee areas of the naproxen and lidocaine gel group by massaging for 2 minutes three times a day for 21 days.

Biological: Naproxen and lidocaine gel

Massage group

PLACEBO COMPARATOR

1 ml of vaseline was applied to both knee areas of the massage group by massaging for 2 minutes three times a day for 21 days.

Biological: Massage

Interventions

1 ml of nigella sativa oil was applied to both knee areas of the nigella sativa oil group by massaging for 2 minutes three times a day for 21 days.

Nigella sativa oil group

1 ml of Naproxen and lidocaine gel was applied to both knee areas of the Naproxen and lidocaine gel group by massaging for 2 minutes three times a day for 21 days.

Naproxen and lidocaine gel group
MassageBIOLOGICAL

1 ml of vaseline was applied to both knee areas of the massage group by massaging for 2 minutes three times a day for 21 days.

Massage group

Eligibility Criteria

Age50 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \- 50 years or older,
  • Can speak Turkish and have no communication problems,
  • Diagnosed with knee OA by the physician according to the ACR criteria, and grade 2-3 according to the radiological classification of Kellgren and Lawrence,
  • Having knee pain in the last three months and needing analgesics more than 15 days in a month,
  • Does not use gel for analgesic purposes locally on the knee area,
  • Able to walk
  • Having crepitus in motion,
  • No inflammatory disease
  • No history of malignancy,
  • Does not have an open wound in the application area,
  • No known allergic condition to Nigella sativa oil, naproxen and lidocaine gel and vaseline,
  • Patients without any psychiatric disorders were included in the study

You may not qualify if:

  • \- under the age of 50,
  • Blindness or deafness
  • Does not speak Turkish and cannot be communicated,
  • Any disease that cannot be cured,
  • Having a physical disability in the area where the application will be made,
  • Any skin disease in the area to be treated,
  • Having large scar tissue in the area to be treated,
  • Having a history of physical trauma in the last three months in the area to be treated,
  • Any peripheral vascular disease in the area to be treated,
  • With inflammatory joint disease,
  • Having a history of rheumatoid arthritis and fibromyalgia,
  • Using any complementary and integrative (integrated) health application in the last three months,
  • Those who have been treated with drugs into the joint in the last three months,
  • Receiving pain blocking therapy in the last year,
  • Receiving physical therapy in the last three months and during the application,
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hitit University

Çorum, 19030, Turkey (Türkiye)

Location

Related Publications (2)

  • Kooshki A, Forouzan R, Rakhshani MH, Mohammadi M. Effect of Topical Application of Nigella Sativa Oil and Oral Acetaminophen on Pain in Elderly with Knee Osteoarthritis: A Crossover Clinical Trial. Electron Physician. 2016 Nov 25;8(11):3193-3197. doi: 10.19082/3193. eCollection 2016 Nov.

    PMID: 28344755BACKGROUND
  • Huseini HF, Kianbakht S, Mirshamsi MH, Zarch AB. Effectiveness of Topical Nigella sativa Seed Oil in the Treatment of Cyclic Mastalgia: A Randomized, Triple-Blind, Active, and Placebo-Controlled Clinical Trial. Planta Med. 2016 Mar;82(4):285-8. doi: 10.1055/s-0035-1558208. Epub 2015 Nov 19.

    PMID: 26584456BACKGROUND

MeSH Terms

Conditions

Osteoarthritis, KneeOsteoarthritisPain

Interventions

Nigella sativa oilNaproxenMassage

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Naphthaleneacetic AcidsNaphthalenesPolycyclic Aromatic HydrocarbonsHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic ChemicalsPolycyclic CompoundsTherapy, Soft TissueMusculoskeletal ManipulationsComplementary TherapiesTherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Lecturer

Study Record Dates

First Submitted

August 28, 2022

First Posted

September 15, 2022

Study Start

February 15, 2021

Primary Completion

February 22, 2021

Study Completion

March 31, 2021

Last Updated

September 14, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will share

De-identified individual participation data will be made available for all outcome measures.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE

Locations